Skip to content
GenoLensGenoLens

MED17

Chr 11q21

mediator complex subunit 17

Aliases:
CRSP77, TRAP80, DRIP80, SRB4
MANE:
ENST00000251871.9

Annotations refreshed 10 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • DDG2P

    BIALLELIC, autosomal or pseudoautosomal
  • Intellectual disability

    BIALLELIC, autosomal or pseudoautosomal
  • Early onset or syndromic epilepsy

    BIALLELIC, autosomal or pseudoautosomal
  • Fetal anomalies

    BIALLELIC, autosomal or pseudoautosomal
  • Severe microcephaly

    BIALLELIC, autosomal or pseudoautosomal

Disease associations (Open Targets)

  • infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly

    0.74
  • hereditary disease

    0.47
  • neurodegenerative disease

    0.46
  • Intellectual disability

    0.12
  • microcephaly

    0.11
  • hepatocellular carcinoma

    0.01
  • Cerebellar atrophy

    0.01
  • epilepsy

    0.00
  • prostate carcinoma

    0.00
  • Familial prostate cancer

    0.00

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Mediator of RNA polymerase II transcription subunit 17

Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.